Treatment response assessment in resistant oral squamous cell carcinoma applying 18F-FDG PET/CT with reference to the Lugano classification
Oral Radiology · 2026
DOI: 10.1007/s11282-025-00856-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Radiology, 2026. Verfasst von Mai Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Carcinoma, Squamous Cell. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
OBJECTIVE: The present study examined the efficacy of the 18F-FDG PET/CT (18F-FDG PET)-based Lugano Classification for Oral Cancer (Lugano-OC) to stage treatment-resistant oral cancer and its utility for predicting treatment responses. PATIENTS AND METHODS: We included 29 oral squamous cell carcinoma (OSCC) patients with disease progression post the primary treatment, who had 18F-FDG PET scans prior to secondary treatment initiation, and were evaluable via Lugano-OC between April 2013 and September 2022. To adapt Lugano-OC to the head and neck region, we designated the clavicle level, a regional lymph node in oral cancer, as the reference standard and visually evaluated 18F-FDG PET accumulation patterns. The primary endpoint was the best overall response, which was assessed according to the Response Evaluation Criteria in Solid Tumors. RESULTS: Patients were categorized into a responder group (n = 7) and non-responder group (n = 22). A univariate analysis revealed significant differences in the CT maximum diameter and metabolic tumor volume (p = 0.050, and 0.037, respectively). A multivariate Cox regression analysis revealed a correlation (hazard ratio 3.59, p = 0.046, 95% confidence interval 1.02-12.6) between Lugano-OC and the duration of treatment responses. CONCLUSION: Among OSCC patients with disease progression post the primary treatment, those with Lugano-OC-localized disease who received radiation chemotherapy had a significantly longer treatment response than patients with advanced-stage disease. These results suggest the predictive value of Lugano-OC for assessing treatment responses in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan. kimmu@gunma-u.ac.jp.
- Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan.
- Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kim, M., Ogawa, M., Suzuki, K., Tokue, A., Higuchi, T., Tsushima, Y., & Yokoo, S. (2026). Treatment response assessment in resistant oral squamous cell carcinoma applying 18F-FDG PET/CT with reference to the Lugano classification. Oral Radiology. https://doi.org/10.1007/s11282-025-00856-9
Vancouver
Kim M, Ogawa M, Suzuki K, Tokue A, Higuchi T, Tsushima Y, et al. Treatment response assessment in resistant oral squamous cell carcinoma applying 18F-FDG PET/CT with reference to the Lugano classification. Oral Radiology. 2026. doi:10.1007/s11282-025-00856-9
BibTeX
@article{Kim2026,
author = {Kim, Mai and Ogawa, Masaru and Suzuki, Keisuke and Tokue, Azusa and Higuchi, Tetsuya and Tsushima, Yoshito and Yokoo, Satoshi},
title = {Treatment response assessment in resistant oral squamous cell carcinoma applying 18F-FDG PET/CT with reference to the Lugano classification},
journal = {Oral Radiology},
year = {2026},
doi = {10.1007/s11282-025-00856-9}
}
EUVIMED